Left ventricular geometric patterns after 1 year of antihypertensive treatment

Manuel Luque1, Nieves Martell, Isabel Egocheaga

  • 1Hypertension Unit, Hospital Clinico San Carlos, Madrid, Spain. mluqueo@telefonica.net

Insights

One year of hypertension treatment lowered left ventricular mass but did not normalize geometry in many patients. Significant left ventricular hypertrophy or remodeling indicates a high-risk subgroup needing aggressive treatment.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Imaging

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular events like myocardial infarction and stroke.
  • Essential hypertension often leads to adaptive changes in the left ventricle.

Purpose of the Study:

  • To assess left ventricular adaptation patterns in essential hypertensives after treatment withdrawal and modification.
  • To evaluate changes in left ventricular mass and geometry following one year of antihypertensive therapy.

Main Methods:

  • Observational study of 107 essential hypertensive patients.
  • Blood pressure and left ventricular mass index (LVMI) measurements before and after 1 year of treatment.
  • Assessment of left ventricular geometry (normal, concentric remodeling, hypertrophy).

Main Results:

  • Blood pressure significantly decreased from 158/96 mm Hg to 137/83 mm Hg (p<0.001).
  • Left ventricular mass index (LVMI) decreased significantly, but only 36% of patients achieved normal left ventricular geometry.
  • Left ventricular geometry improved in 31%, remained unchanged in 51%, and worsened in 18% of patients.

Conclusions:

  • Suboptimal antihypertensive treatment can reduce LVMI but often leaves significant LVH or concentric remodeling.
  • A substantial proportion of patients remain at high cardiovascular risk despite treatment.
  • Aggressive antihypertensive strategies are recommended for patients with persistent LVH or remodeling.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...